Arch. Endocrinol. Metab. 2018;62(1):34-40
Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers
DOI: 10.20945/2359-3997000000006
ABSTRACT
Objective
The aim of this research was to analyze the expression profile of miR-155, miR-146a, and miR-326 in peripheral blood mononuclear cells (PBMC) of 47 patients with type 1 diabetes mellitus (T1D) and 39 control subjects, as well as the possible association with autoimmune or inflammatory markers.
Subjects and methods
Expression profile of miRs by means of qPCR using TaqMan probes. Autoantibodies and inflammatory markers by ELISA. Statistical analysis using bivariate correlation.
Results
The analysis of the results shows an increase in the expression of miR-155 in T1D patients in basal conditions compared to the controls (p < 0.001) and a decreased expression level of miR-326 (p < 0.01) and miR-146a (p < 0.05) compared T1D patients to the controls. miR-155 was the only miRs associated with autoinmmunity (ZnT8) and inflammatory status (vCAM).
Conclusion
Our data show a possible role of miR-155 related to autoimmunity and inflammation in Chilean patients with T1D.
Keywords: autoimmunity; inflammation; miRNAs; Type 1 diabetes
